Healthcare -
Biotechnology - NASDAQ - CH
$ 40.53
0.571 %
$ 3.46 B
Market Cap
-14.53
P/E
CRSP - REVENUE
Revenue CRSP - CRISPR Therapeutics AG
371 M
LAST VALUE
-36.24%
2 YEAR CAGR
160.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR